Skip to content
HowShorted

TG THERAPEUTICS, INC. short interest in 2021

In 2021, TG THERAPEUTICS, INC.'s disclosed short interest ran from 9.55% of shares outstanding on 15 Jan 2021 to 10.75% on 31 Dec 2021, a change of +1.20 percentage points. The year's high was 10.75% on 31 Dec 2021 and its low 7.61% on 30 Jun 2021, averaging 8.99% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.48 days on 29 Oct 2021. Full history: TG THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for TG THERAPEUTICS, INC. in 2021

2021 in figures

Start of year
9.55% (15 Jan 2021)
End of year
10.75% (31 Dec 2021)
Change
+1.20 pp
High
10.75% (31 Dec 2021)
Low
7.61% (30 Jun 2021)
Average
8.99%
Highest days to cover
22.48 (29 Oct 2021)
SEC filings marked
8

Every report in 2021

TG THERAPEUTICS, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20219.55%7.76
29 Jan 20219.13%9.59
12 Feb 20218.95%7.75
26 Feb 20219.00%10.52
15 Mar 20219.09%9.1110-K filed, results (8-K)
31 Mar 20218.98%8.90
15 Apr 20218.49%11.97
30 Apr 20218.56%6.86
14 May 20218.17%8.5510-Q filed, results (8-K)
28 May 20218.31%8.66
15 Jun 20218.08%11.01
30 Jun 20217.61%10.44
15 Jul 20217.81%15.77
30 Jul 20218.00%15.84
13 Aug 20218.98%4.09results (8-K), 10-Q filed
31 Aug 20219.69%7.12
15 Sep 20219.10%9.41
30 Sep 20219.47%10.85
15 Oct 20219.59%18.29
29 Oct 20219.42%22.48
15 Nov 20219.47%10.60results (8-K), 10-Q filed
30 Nov 20219.36%3.86
15 Dec 202110.16%6.49
31 Dec 202110.75%9.48

See also: TG THERAPEUTICS, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.